Table 1.
CHARACTERISTICS | TREATMENT GROUP | ||
---|---|---|---|
ED&C (N=149) |
Excision or Mohs Surgery (n=568) |
Pb | |
PATIENT CHARACTERISTICS | |||
Age, years, median (IQR) | 66 (54–76) | 69 (56–77) | .08 |
Gender male | 79% | 76% | .42 |
Income ≤$30,000 | 49% | 53% | .30 |
History of prior NMSC | 43% | 48% | .30 |
Number of NMSCs at presentation, mean ± Standard Deviation | 1.3±0.6 | 1.3±0.7 | .95 |
TUMOR CHARACTERISTICS | |||
HISTOLOGICAL TYPE, Basal Cell Carcinoma | 80% | 73% | .10 |
Invasive | 44% | 82% | <.001 |
Histopathological risk factor for recurrence1 | 6% | 26% | <.001 |
Tumor diameter, mm, median (IQR) | 8 (5–12) | 8 (5–12) | .63 |
Tumor Present on Face, Scalp or Neck | 28% | 79% | <.001 |
CARE CHARACTERISTICS | |||
Treatment Site, Veteran Affairs Medical Center (VA) | 44% | 51% | .12 |
Training level of treating clinician, Attending Physician | 52% | 69% | <.001 |
Annual dermatology visits over follow-up period, median (IQR) | 1.8 (1.0–2.8) | 1.7 (0.6–3.1) | .18 |
Number of Cycles of ED&C Performed, mean±SD | 2.9±.36 | NA | NA |
Closure type | |||
Secondary intention | 100% | 11% | <.001 |
Primary linear closure | 0% | 68% | |
Use of flap or graft | 0% | 19% | |
Other | 0% | 2% |
Data were missing for the ED&C group/Excision or Mohs group for the following number of patients or tumors: income 13/37, skin type 7/80, health status 12/53, tumor diameter 52/39, training level of clinician 11/8, cycles of ED&C 32, and closure type 7/33.
P value refers to comparison of ED&C group to Excision/Mohs group